A notable reduction in crystal meth use was observed among those who used cannabis for craving management.
Medical cannabis was rated as more positive in terms of emotional and holistic effects.
37% of GPs surveyed believe that medical cannabis has the potential to reduce patient dependency on other medications.
Recent studies find CBD may help curb opioid cravings and enhance the effects of the opioid antidote, naloxone.
Researchers identified a ‘significant decrease’ in financial interactions between opioid manufacturers and physicians as an effect of medical cannabis legalisation.
Opioid use decreased following cannabis therapy and this decline grew more significantly over time.
Dr Nat Wright, clinical advisor to AltoVerde, discusses the role of cannabis in tackling substance misuse and the over-prescribing of opioids.
Researchers found a reduction of 26% in pharmacy-based distribution of codeine in states where cannabis was legal.
Cancer patients used less opioids to manage their pain in states where medical cannabis had been legalised.
73 per cent of patients were able to decrease or stop their opioid consumption all together.
